These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22941884)

  • 1. Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.
    Glasgow CG; El-Chemaly S; Moss J
    Eur Respir Rev; 2012 Sep; 21(125):196-206. PubMed ID: 22941884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic involvement in lymphangioleiomyomatosis.
    Glasgow CG; Taveira-Dasilva AM; Darling TN; Moss J
    Ann N Y Acad Sci; 2008; 1131():206-14. PubMed ID: 18519973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of lymphatics in lymphangioleiomyomatosis.
    Glasgow CG; Taveira-DaSilva A; Pacheco-Rodriguez G; Steagall WK; Tsukada K; Cai X; El-Chemaly S; Moss J
    Lymphat Res Biol; 2009 Dec; 7(4):221-8. PubMed ID: 20143921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic manifestations of lymphangioleiomyomatosis.
    Gupta R; Kitaichi M; Inoue Y; Kotloff R; McCormack FX
    Lymphology; 2014 Sep; 47(3):106-17. PubMed ID: 25420303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.
    Kumasaka T; Seyama K; Mitani K; Sato T; Souma S; Kondo T; Hayashi S; Minami M; Uekusa T; Fukuchi Y; Suda K
    Am J Surg Pathol; 2004 Aug; 28(8):1007-16. PubMed ID: 15252306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
    Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
    Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangioleiomyomatosis: a disease involving the lymphatic system.
    Seyama K; Kumasaka T; Kurihara M; Mitani K; Sato T
    Lymphat Res Biol; 2010 Mar; 8(1):21-31. PubMed ID: 20235884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.
    Glasgow CG; Avila NA; Lin JP; Stylianou MP; Moss J
    Chest; 2009 May; 135(5):1293-1300. PubMed ID: 19420197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis.
    Kumasaka T; Seyama K; Mitani K; Souma S; Kashiwagi S; Hebisawa A; Sato T; Kubo H; Gomi K; Shibuya K; Fukuchi Y; Suda K
    Am J Surg Pathol; 2005 Oct; 29(10):1356-66. PubMed ID: 16160479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.
    Krymskaya VP
    Proc Am Thorac Soc; 2008 Jan; 5(1):119-26. PubMed ID: 18094094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
    Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
    Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis.
    Inoue Y; King TE; Barker E; Daniloff E; Newman LS
    Am J Respir Crit Care Med; 2002 Sep; 166(5):765-73. PubMed ID: 12204879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangioleiomyomatosis: what do we know and what are we looking for?
    Harari S; Torre O; Moss J
    Eur Respir Rev; 2011 Mar; 20(119):34-44. PubMed ID: 21357890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
    Ando K; Fujino N; Mitani K; Ota C; Okada Y; Kondo T; Mizobuchi T; Kurihara M; Suzuki K; Hoshika Y; Ebana H; Kobayashi E; Takahashi K; Kubo H; Seyama K
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L899-908. PubMed ID: 27016587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
    Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
    Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular insights into lymphangioleiomyomatosis.
    Steagall WK; Taveira-DaSilva AM; Moss J
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangioleiomyomatosis: Current understanding and potential treatments.
    Moir LM
    Pharmacol Ther; 2016 Feb; 158():114-24. PubMed ID: 26713679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
    Liu HJ; Krymskaya VP; Henske EP
    Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.
    Cai X; Pacheco-Rodriguez G; Fan QY; Haughey M; Samsel L; El-Chemaly S; Wu HP; McCoy JP; Steagall WK; Lin JP; Darling TN; Moss J
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1410-8. PubMed ID: 20639436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.
    Yue M; Pacheco G; Cheng T; Li J; Wang Y; Henske EP; Schuger L
    Am J Pathol; 2016 Jul; 186(7):1825-1836. PubMed ID: 27289491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.